Vanda Pharmaceuticals Inc (VNDA)
EBITDA Margin
-121.77%
Quarterly · Period ending:
VNDA EBITDA Margin
Latest reported-121.77%period ending
Latest reported-121.77%period ending
VNDA Quarterly EBITDA Margin (0.00% → -121.77%)
Quarterly ebitda margin
High-resolution chart · PNG
VNDA ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -121.7697% | |
| -86.8112% | |
| -56.1714% | |
| -46.8147% | |
| -62.5005% | |
| -60.1747% | |
| -8.5062% | |
| -8.9757% | |
| -7.0294% | |
| -5.141% | |
| -1.1111% | |
| 1.1851% | |
| 6.935% | |
| 9.9171% | |
| 15.9362% | |
| 9.3986% | |
| 6.9576% | |
| -11.4002% | |
| 13.6962% | |
| 16.3064% | |
| 19.6115% | |
| 17.6419% | |
| 17.201% | |
| 14.028% | |
| 15.8873% | |
| 1.0276% | |
| 8.17% | |
| 21.8576% | |
| 20.7636% | |
| -2.8818% | |
| 18.6686% | |
| 14.2078% | |
| 9.8585% | |
| 7.21% | |
| -3.1146% | |
| -10.0373% | |
| -2.8272% | |
| -19.249% | |
| 4.5288% | |
| 6.5199% | |
| -4.5269% | |
| -27.9989% | |
| -37.0122% | |
| -22.7244% | |
| -8.6759% | |
| -27.1287% | |
| -47.1893% | |
| -5.2767% | |
| -191.9536% | |
| -283.1456% | |
| -81.7374% | |
| -56.7803% | |
| -35.2927% | |
| -50.6817% | |
| -75.0758% | |
| -59.2905% | |
| -90.9525% | |
| -93.5634% | |
| -63.871% | |
| -34.7597% | |
| -14.5357% | |
| 0.0933% | |
| 16.0702% | |
| 10.2639% | |
| 19.4697% | |
| 53.217% | |
| -194.7047% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -575.4786% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |